Pharma startup gets $30M for genetic cancer treatments
Source: Venture Beat
Arch :: Switzerland | updated 2013-04-11 18:59:08 -0700 | health-news
This is the company's first round of institutional funding, making the $30 million figure even more remarkable. The capital will be used to fast-track discovery and development of gene control medicines. The life sciences company is developing breakthroughs in gene...
Cartoons of The Day
Build Your Allvoices Brand. Gain Influence. Make Money.
News From Hot Locations
